MSLN STAR-T Cells in the Treatment of Advanced Malignant Solid Tumors
Clinical trial NCT05344976 · UNKNOWN
Trial details
- NCT number
- NCT05344976
- Sponsor
- Peking University
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-14
- Primary completion
- 2024-10-14
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.